US Patent 8679505 Compositions for immunising against

Patent 8679505 was granted and assigned to Novartis on March, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8679505

Date of Patent

March 25, 2014

Patent Application Number

13264369

Date Filed

April 14, 2010

Patent Citations Received

‌

US Patent 12077795 Method for biocatalytic protein-oligonucleotide conjugation

Patent Primary Examiner

‌

Padma V Baskar

Patent abstract

An effective Staphylococcus aureus vaccine may require several antigenic components, and so various combinations of S. aureus antigens are identified for use in immunization. These polypeptides may optionally be used in combination with S. aureus saccharides.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8679505 Compositions for immunising against

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API